Sagimet Biosciences reported cash from operations of -$11.10M and free cash flow of -$11.10M for the quarter ended Jun 2026, down 22.0% year over year. This cash flow statement covers 17 quarters of results from Jun 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||
| Net Income | -7.34M | -7.47M | -7.20M | -6.69M | -7.04M | -6.36M | -8.15M | -8.79M | -10.62M | -14.62M | -16.20M | -19.97M | -10.39M | -12.91M | -9.57M | -11.82M | -13.95M |
| Share-based Compensation | 0.38M | 0.39M | 0.72M | 0.77M | 3.78M | 3.77M | 1.31M | 3.52M | 4.46M | 4.32M | 1.53M | 5.49M | 5.74M | 5.69M | 1.69M | 6.44M | 7.57M |
| Gains from Investment Securities | -0.00M | 0.00M | -0.00M | -0.00M | |||||||||||||
| Cash from Operations | -0.00M | -6.23M | -7.45M | -7.08M | -5.72M | -3.88M | -7.08M | -6.21M | -5.63M | -19.57M | -11.02M | -14.54M | -9.10M | -10.18M | -11.83M | -8.61M | -11.10M |
| Depreciation, Depletion & Amortization | |||||||||||||||||
| Amortizatization of Intangibles | 0.09M | 0.08M | 0.04M | 0.00M | -0.00M | 0.19M | 0.48M | 0.53M | 0.06M | 0.54M | 0.23M | -0.07M | -0.30M | 0.14M | 0.02M | ||
| Change in Working Capital | |||||||||||||||||
| Change in Accured Expenses | 1.05M | -1.00M | -1.19M | -0.40M | 1.39M | 0.32M | -0.78M | 1.09M | -1.66M | 0.44M | 3.39M | -0.05M | 1.56M | -3.97M | 0.64M | -0.24M | |
| Other Working Capital Changes | 0.12M | -0.11M | 0.04M | -0.41M | 0.77M | 0.56M | -0.64M | -0.41M | 4.31M | -3.40M | 0.69M | 0.04M | 0.82M | 0.28M | 0.30M | 0.53M | |
| Investing Activities | |||||||||||||||||
| Change in Acquisitions & Divestments | 5.44M | 19.40M | 12.80M | 3.00M | 7.79M | 12.00M | 23.61M | 18.99M | 29.66M | 31.34M | 31.43M | 16.97M | 15.88M | ||||
| Cash from Investing Activities | 4.00M | 5.44M | 19.40M | 12.80M | -19.62M | 3.00M | -75.16M | 0.62M | 9.85M | 3.41M | -13.29M | 0.07M | 14.36M | 10.22M | -24.02M | ||
| Financing Activities | |||||||||||||||||
| Other financing activities | 0.06M | 0.14M | 0.91M | 85.11M | 3.52M | 1.02M | 0.03M | 0.30M | -0.03M | ||||||||
| Change in Capital Stock | |||||||||||||||||
| Net Shares Issued and Repurchased | 0.59M | 0.26M | 1.63M | 1.03M | 1.34M | 0.72M | |||||||||||
| Net Equity Issued and Repurchased | 105.75M | ||||||||||||||||
| Misc. | |||||||||||||||||
| Cash from Financing Activities | -0.06M | -0.14M | -0.91M | 87.21M | 104.85M | -0.03M | 0.27M | ||||||||||
| Change in Cash | -2.23M | 156.19M | 12.18M | 6.17M | 83.33M | -99.81M | 101.64M | -80.82M | |||||||||
| Free Cash Flow | -0.00M | -6.23M | -7.45M | -7.08M | -5.72M | -3.88M | -7.08M | -6.21M | -5.63M | -19.57M | -11.02M | -14.54M | -9.10M | -10.18M | -11.83M | -8.61M | -11.10M |
| Net Cash Flow | -0.00M | -2.23M | -2.07M | 12.18M | 6.17M | 83.33M | -26.70M | 101.64M | -80.82M | -18.95M | -1.17M | -11.12M | -22.39M | -9.83M | 2.52M | 1.60M | -35.12M |